Eric Johannsen

5.5k total citations
66 papers, 4.0k citations indexed

About

Eric Johannsen is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Eric Johannsen has authored 66 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 30 papers in Pathology and Forensic Medicine and 22 papers in Immunology. Recurrent topics in Eric Johannsen's work include Viral-associated cancers and disorders (56 papers), Lymphoma Diagnosis and Treatment (30 papers) and Cytomegalovirus and herpesvirus research (19 papers). Eric Johannsen is often cited by papers focused on Viral-associated cancers and disorders (56 papers), Lymphoma Diagnosis and Treatment (30 papers) and Cytomegalovirus and herpesvirus research (19 papers). Eric Johannsen collaborates with scholars based in United States, United Kingdom and Japan. Eric Johannsen's co-authors include Elliott Kieff, Sharon R. Grossman, Bo Zhao, Tong Xiao, Diego Illanes, Michael R. Chase, Michael A. Calderwood, Ramana R. Yalamanchili, Seiji Maruo and Ellen Cahir-McFarland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Eric Johannsen

64 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Johannsen United States 36 2.7k 1.3k 1.2k 1.1k 996 66 4.0k
Bo Zhao United States 37 2.2k 0.8× 821 0.7× 976 0.8× 1.5k 1.4× 962 1.0× 99 3.8k
F Sigaux France 28 2.2k 0.8× 1.1k 0.9× 953 0.8× 666 0.6× 876 0.9× 69 4.0k
Martin J. Allday United Kingdom 45 4.2k 1.5× 1.4k 1.1× 1.6k 1.3× 1.9k 1.8× 1.0k 1.0× 73 5.5k
Debbie Croom-Carter United Kingdom 24 2.5k 0.9× 674 0.5× 1.4k 1.2× 412 0.4× 1.1k 1.1× 26 3.2k
Joyce D. Fingeroth United States 26 1.8k 0.7× 1000 0.8× 661 0.6× 473 0.4× 1.2k 1.2× 45 3.1k
Micah A. Luftig United States 30 1.7k 0.6× 1.1k 0.9× 549 0.5× 976 0.9× 887 0.9× 68 3.0k
Dagmar Pich Germany 21 1.5k 0.6× 935 0.7× 468 0.4× 679 0.6× 563 0.6× 29 2.3k
Frank Neipel Germany 30 3.1k 1.1× 2.3k 1.8× 638 0.5× 984 0.9× 1.1k 1.1× 59 4.5k
A. B. Rickinson United Kingdom 31 2.9k 1.1× 960 0.8× 1.6k 1.3× 407 0.4× 1.8k 1.8× 51 4.2k
David Liebowitz United States 16 1.6k 0.6× 352 0.3× 751 0.6× 387 0.4× 479 0.5× 22 2.3k

Countries citing papers authored by Eric Johannsen

Since Specialization
Citations

This map shows the geographic impact of Eric Johannsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Johannsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Johannsen more than expected).

Fields of papers citing papers by Eric Johannsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Johannsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Johannsen. The network helps show where Eric Johannsen may publish in the future.

Co-authorship network of co-authors of Eric Johannsen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Johannsen. A scholar is included among the top collaborators of Eric Johannsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Johannsen. Eric Johannsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baiu, Dana C., Joshua Brand, Huy Q. Dinh, et al.. (2025). CD8+ T-cell Antitumor Immunity via Human iNKT–DC Conjugates. Cancer Immunology Research. 14(2). 318–334.
2.
Johannsen, Eric, et al.. (2025). LMP2A—The Other EBV Oncogene. Current topics in microbiology and immunology.
3.
Bristol, Jillian A., Scott E. Nelson, Makoto Ohashi, et al.. (2024). Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice. PLoS Pathogens. 20(4). e1012132–e1012132. 4 indexed citations
4.
Johannsen, Eric, et al.. (2023). EBV Reactivation from Latency Is a Degrading Experience for the Host. Viruses. 15(3). 726–726. 9 indexed citations
5.
Bristol, Jillian A., Joshua Brand, Makoto Ohashi, et al.. (2022). Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. PLoS Pathogens. 18(4). e1010453–e1010453. 15 indexed citations
6.
Ali, Ahmed, et al.. (2022). Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription. PLoS Pathogens. 18(9). e1010886–e1010886. 13 indexed citations
7.
Singh, Deo R., Scott E. Nelson, Jillian A. Bristol, et al.. (2022). Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. PLoS Pathogens. 18(10). e1010868–e1010868. 5 indexed citations
8.
Ohashi, Makoto, Dhananjay M. Nawandar, Denis Lee, et al.. (2021). ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PLoS Pathogens. 17(11). e1010045–e1010045. 12 indexed citations
9.
Ohashi, Makoto, et al.. (2021). Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathogens. 17(8). e1009783–e1009783. 19 indexed citations
10.
11.
Romero-Masters, James C., Shane M. Huebner, Makoto Ohashi, et al.. (2020). B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathogens. 16(2). e1008365–e1008365. 31 indexed citations
12.
Hayes, Mitchell, et al.. (2018). CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PLoS Pathogens. 14(6). e1007114–e1007114. 38 indexed citations
13.
Bristol, Jillian A., Carrie B. Coleman, Makoto Ohashi, et al.. (2018). A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathogens. 14(7). e1007179–e1007179. 76 indexed citations
14.
Kraus, Richard J., Xianming Yu, Tawin Iempridee, et al.. (2017). Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathogens. 13(6). e1006404–e1006404. 57 indexed citations
15.
Zhou, Hufeng, Sizun Jiang, Katharina Bernhardt, et al.. (2015). Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth. Cell Host & Microbe. 17(2). 205–216. 136 indexed citations
16.
Duarte, Melissa, Michael A. Calderwood, Guillaume Adelmant, et al.. (2013). An RS Motif within the Epstein-Barr Virus BLRF2 Tegument Protein Is Phosphorylated by SRPK2 and Is Important for Viral Replication. PLoS ONE. 8(1). e53512–e53512. 18 indexed citations
17.
Johannsen, Eric & Paul F. Lambert. (2013). Epigenetics of human papillomaviruses. Virology. 445(1-2). 205–212. 75 indexed citations
18.
Zhao, Bo, et al.. (2011). EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proceedings of the National Academy of Sciences. 108(19). 7808–7813. 34 indexed citations
19.
Calderwood, Michael A., Sung Wook Lee, Amy M. Holthaus, et al.. (2011). Epstein–Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; Only the NTD interaction is essential for lymphoblastoid cell growth. Virology. 414(1). 19–25. 15 indexed citations
20.
Johannsen, Eric, Costi D. Sifri, & Lawrence C. Madoff. (2000). PYOGENIC LIVER ABSCESSES. Infectious Disease Clinics of North America. 14(3). 547–563. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Zhao Breakdown of academic impact, for papers by F Sigaux Breakdown of academic impact, for papers by Martin J. Allday Breakdown of academic impact, for papers by Debbie Croom-Carter Breakdown of academic impact, for papers by Joyce D. Fingeroth Breakdown of academic impact, for papers by Micah A. Luftig Breakdown of academic impact, for papers by Dagmar Pich Breakdown of academic impact, for papers by Frank Neipel Breakdown of academic impact, for papers by A. B. Rickinson Breakdown of academic impact, for papers by David Liebowitz
Rankless by CCL
2026